Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
European Journal of Cancer (Oxford, England : 1990)|December 29, 2018
A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancerY-J Bang, Y-K Kang, M Ng, et al.
Cancer|January 3, 2001
Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in premenopausal women with axillary lymph node positive breast carcinomaS M Bang, D S Heo, K H Lee, et al.
The Journal of Biological Chemistry|February 7, 1998
A novel ets-related transcription factor, ERT/ESX/ESE-1, regulates expression of the transforming growth factor-beta type II receptorS G Choi, Y Yi, Y S Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancerH M Chang, K H Jung, T-Y Kim, et al.
Cancer|November 20, 1997
Alterations of p16INK4A and p15INK4B genes in gastric carcinomasY Y Lee, S H Kang, J Y Seo, et al.
Cancer|April 13, 2001
A Phase I study of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-1,3-dioxolane] platinum(II) in patients with advanced malignanciesN K Kim, T Y Kim, S G Shin, et al.
Investigational New Drugs|October 5, 2013
Phase I study of sunitinib plus capecitabine/cisplatin or capecitabine/oxaliplatin in advanced gastric cancerK-W Lee, S R Park, D-Y Oh, et al.
Journal of Korean Medical Science|September 1, 1987
Intracranial granulocytic sarcoma (chloroma) in a nonleukemic patientD H Yoon, K J Cho, Y L Suh, et al.
Anticancer Research|July 23, 1998
Natural killer cell activity depression in peripheral blood and ascites from gastric cancer patients with high TGF-beta 1 expressionS J Yoon, D S Heo, S H Kang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2017
A randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with FGFR2 polysomy or gene amplificationE Van Cutsem, Y-J Bang, W Mansoor, et al.
Pageof 10